Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element

DNA and Cell Biology

Volumn 21, Issue 8, 2002, Pages 581-586

  Locher, Christopher P ^a   Witt, Stephanie A ^a   Ashlock, Brittany M ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA VACCINE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; EXPRESSION VECTOR; FEMALE; GENETIC ANALYSIS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROVIRUS; TRANSCRIPTION REGULATION; VACCINATION; VIRUS GENE;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL TRANSPORT; CELL LINE; FEMALE; GENE PRODUCTS, ENV; GENETIC VECTORS; HIV-2; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; PROTEIN PRECURSORS; REGULATORY SEQUENCES, NUCLEIC ACID; VACCINES, DNA;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; MAMMALIA; RNA VIRUSES; SIMIAE; UNIDENTIFIED RETROVIRUS; VECTORS;

EID: 0036377409     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454902320308951     Document Type: Article

References (33)

1. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
2. The evolution of DNA vaccines
3. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
4. UC2
5. Persistent infection of baboons and rhesus monkeys with different strains of HIV-2
6. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
7. DNA vaccination with the human immunodeficiency virus type 1 SF162DeltaV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques
8. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection
9. Technologies for the design, discovery, formulation and administration of vaccines
10. Evaluation of novel control elements by construction of eukaryotic expression vectors
11. Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina
12. Codon usage limitation in the expression of HIV-1 envelope glycoprotein
13. An improved plasmid DNA expression vector for direct injection into skeletal muscle
14. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor
15. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts
16. Cellular proteins that bind to the hepatitis B and posttranscriptional regulatory element
17. DNA immunization of mice against SIVmac239 gag and Env using Rev-independen t expression plasmids
18. Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element
19. Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants
20. Development of improved vectors for DNA-based immunization and other gene therapy applications
21. A single immunization with a plasmid encoding hepatitis C virus (HCV) structural proteins under the elongation factor 1-alpha promoter elicits HCV-specific cytotoxic T-lymphocytes (CTL)
22. Recent developments in adjuvants for vaccines against infectious diseases
23. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner
24. DNA vaccines for immunodeficiency viruses
25. Engineering of DNA vaccines using molecular adjuvant plasmids
26. The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function
27. Genetic immunization is a simple method for eliciting an immune response
28. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen
29. DNA vaccines
30. Immunostimulatory DNA sequences, an overview
31. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles
32. Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 gag expression in a context-dependent manner
33. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene